Trial phases explained in plain language, with Clinical Tracker

Phase 1 trials are usually the earliest stage in people. In plain terms, they mostly ask whether something can be given safely and at what dose, often with a small group. They are not designed to prove that a treatment works.

Say, for example, you find a Phase 1 study listed as not yet recruiting. You add it to your watchlist. When its status changes to Recruiting, the alert tells you, and you can open the registry link and bring the details to your care team.

Phase 2 trials generally look at whether an approach shows signs of benefit and keep studying safety in a larger group. The key idea is early evidence, not a final answer.

For example, a family has been watching a Phase 2 study that was too far away. One day it changes to Recruiting and adds two new sites. The alert says so, with the registry link. They check the locations and decide whether to ask the doctor about it.

Phase 3 trials are typically larger and compare a new approach with the current standard care, to see how it holds up over more people and more time. They are often the last step before regulators review the results.

If you are weighing several Phase 3 studies, search for them in Clinical Tracker and watch the ones that fit. When any of them changes, you hear about it, instead of rereading every page each week.

Phase 4 studies usually happen after a treatment is already available, looking at long-term effects in everyday use. Knowing this helps you read the label correctly: a Phase 4 listing is not a brand new experiment.

You can still watch these listings for changes the same way, and ask your doctor what the findings mean for you.